Contract Manufacturing

Cancer Research UK backs Hummingbird’s cancer treatment development

13-Aug-2019 By Vassia Barba

Cancer Research UK to support the clinical development of Hummingbird’s investigative cancer treatment which has the potential to fight drug resistant tumours.

The complete package: Sartorius Stedim adds cell bank manufacture

12-Aug-2019 By Maggie Lynch

Sartorius Stedim to offer the GMP manufacture of mammalian cell banks for the biopharmaceutical industry alongside characterization services.

Permira Funds acquires Cambrex in $2.4bn deal

08-Aug-2019 By Vassia Barba

Cambrex is acquired by an affiliate of Permira Funds for $2.4bn, and will continue investing ‘aggressively’ to support its global customer base.

People on the Move: Outsourcing-Pharma roundup July ‘19

02-Aug-2019 By Melissa Fassbender

CordenPharma has a new CEO, Arbour Group advances plans to expand in RTP, Ashfield brings on a former Iqvia VP, and Recursion adds to its c-suite after raising $121m this month.

Quotient to ‘stretch’ core CDMO business with new PE owners

22-Jul-2019 By Melissa Fassbender

Quotient Sciences has found new owners in the UK-based PE firm, Permira, as the CDMO eyes new opportunities to expand its business into adjacent service sectors and new geographies, says CEO.

Reactor malfunction results in employee death at India-based CRO

11-Jul-2019 By Melissa Fassbender

One worker has died at GVK Bio’s Hyderabad site after a reactor malfunctioned, though the root cause remains unknown, according to the CRO.

Wasdell opens doors at EU headquarters

08-Jul-2019 By Melissa Fassbender

The company initiates operations at its new EU headquarters in Dundalk, Ireland after receiving its manufacturing and importation authorization license from the HPRA.

People on the Move: Outsourcing-Pharma roundup June ‘19

03-Jul-2019 By Melissa Fassbender

Newly-minted Signant Health named a new CTO, Parexel bolstered its Japan presence, and BioAgilytix’s CEO was appointed to the board of FSD Pharma – a company developing products based on cannabinoids – among other people on the move in June.

Amicus picks Brammer for preclinical, clinical gene therapy work

02-Jul-2019 By Vassia Barba

Rare disease drug developer to work with Brammer Bio – which Thermo Fisher acquired in March – on gene therapy programs against Batten disease.

Acquisition of Novartis’ Swiss site gives Lonza its first sterile drug product facility

01-Jul-2019 By Maggie Lynch

Lonza adds its first sterile drug product fill-finish facility to its network after acquiring Novartis’ Swiss plant, building on its parenteral drug product development and testing capabilities for clinical trial supply.

Seqens opens collaborative R&D space after an ‘epiphany’

24-Jun-2019 By Maggie Lynch

Seqens opens new center of excellence that houses R&D capabilities, onsite consulting, and space for coworking and collaboration in Porcheville, France.

Concept Life Sciences providing ‘fully integrated offering’ in the early development space

24-Jun-2019 By Melissa Fassbender

The drug discovery, development, and analytical service provider has opened a new facility in Sandwich, UK to support the development and manufacturing of APIs – a market expected to top $270bn by 2026.

Catalent enters AAV vector production agreement with IVERIC bio

18-Jun-2019 By Maggie Lynch

Catalent is producing AAV vectors for the preclinical and clinical trial supply of Iveric bio’s lead drug candidates.

Almac meets evolving trial design with ‘on demand’ supply solution

17-Jun-2019 By Maggie Lynch

In an aim to optimize the performance of changing clinical trials, Almac Clinical Services launched a supply chain solution – Almac Adapt – to provide sponsors with an adaptive supply strategy.

NanoComposix adds drug manufacturing to services roster

13-Jun-2019 By Melissa Fassbender

San Diego, CA-based NanoComposix received its drug manufacturing license which it said will ensure clients are able to use one vendor throughout the product life cycle.